Concentration of platelet derived-growth factors in concentrates used to regenerate injured bone tissue;Ocena ste{ogonek}żenia czynników wzrostu pochodzenia plytkowego w koncentracie stosowanym w celu regeneracji uszkodzonej tkanki kostnej

Ortopedia Traumatologia Rehabilitacja

Volumn 15, Issue 5, 2013, Pages 379-388

  Korsak, Jolanta ^a   Rzeszotarska, A ^a   Marczyński, Wojciech ^b   Jablońska, Iwona ^b   Bialecki, Jerzy ^b   Walczak, Piotr ^b  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b Department of Orthopedic Surgery   (Poland)

Author keywords

Blood platelets; Bone union; Growth factors; Stimulation of healing; Validation

Indexed keywords

BLOOD CLOTTING FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

BONE REGENERATION; HUMAN; METABOLISM; PHYSIOLOGY; THROMBOCYTE RICH PLASMA;

BLOOD COAGULATION FACTORS; BONE REGENERATION; HUMANS; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84892681736     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: 10.5604/15093492.1084239     Document Type: Article

References (23)

1. Woolf AD, Pfleyer B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-656.
2. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008;1:165-174.
3. Anitua M, Sanchez E, Nurden A, et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006;24:227-234.
4. Jurk K, Kehrel BE. Platelets physiology and biochemistry. Semin Thromb Hemost 2005;31:281-392.
5. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006.
6. Barret S, Erredge S. Growth factors for chronic plantar fasciitis. Pediatry Today 2004;17:37-42.
7. Tate KS, Crane DM. Platelet Rich Plasma Grafts in Musculoskeletal Medicine. J Prolotherapy 2010;2:371-376.
8. Rožman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatoven APA 2007; 16:156-165.
9. Cieślik-Bielecka A, Bielecki T, Gaździk TSz, Cieślik T. Czynniki wzrostu zawarte w osoczu bogatoplytkowym jako autogennym material stymuluja{ogonek}cym procesy gojenia tkanki kostnej. Czas Stomatol 2006;7:510-517.
10. Jiang Di, Dziak R, Lynch SE, Stephan EB. Modification of an osteoconductive anorganic bovine bone mineral matrix with growth factors. J Periodontol 1999;70:834-839.
11. Barzini P, Mazzucco L. Tissue regeneration and in loco administration of platelet derivatives: Clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion 2005;45:1759-1767.
12. Sanchez M, et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sp Med 2007.
13. Hee, et al. Do autologous growth factors enhance transforaminal lumbar interbody fusion? Eur Spine J 2003;12:400-407.
14. Marx RE, Carlson E, Eichstaedt RM et al. Platelet-Rich Plasma: Growth factors enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-646.
15. Menetrey J, Kasmkijwattana C, Day CS, et al. Growth facrors improve muscle healing in vivo. J Bone Joint Surg Br 2000; 82:131-137.
16. Antitua E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF productions by human tendon cells in culture. J Orthop Res 2005;23:281-286.
17. Plow EF, Ginsberg MH. The molecular basis for platelet function. W: Hoffman R, Benz EJ, Shattil SJ, et al (ed). Hematology. Basic principles and practice. Chuchill Livigstone 2000:1741-1752.
18. Mazzucco L, Medici D, Serra M, et al. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004;44:1013-1018.
19. Su Chen Y, Kuo YP, Lin YC, et al. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008;48:2414-2420.
20. Su Chen Y, Kuo YP, Lin YC, et al. A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sang 2009;97:119-128.
21. Mazzucco L, Balbo V, Cattana E, et al. Not every PRP-gel is born equal evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009;97:110-118.
22. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on Peri-implant bone regeneration. Bone 2004;34:665-671.
23. Weibrich G, Kleis W, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP Kit versus PCCS PRP System. Intern J Oral and Maxill Implants 2002;17:184-190.